Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

Digestive and Liver Disease

Volumn 42, Issue 7, 2010, Pages 503-508

  Lee, Jeong Hoon ^a   Kim, Donghee ^b   Kim, Hwa Jung ^a,c   Lee, Chang Hoon ^a   Yang, Jong In ^b   Kim, Won ^a   Kim, Yoon Jun ^a   Yoon, Jung Hwan ^a   Cho, Sang Heon ^b   Sung, Myung Whun ^b   Lee, Hyo Suk ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

Body mass index; Fatty liver; Hepatic steatosis index; Screening

Indexed keywords

ALANINE AMINOTRANSFERASE; AMIODARONE; ASPARTATE AMINOTRANSFERASE; DILTIAZEM; ESTROGEN; METHOTREXATE; STEROID; TAMOXIFEN; VALPROIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SCREENING TEST;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; ROC CURVE; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 77955553316     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.08.002     Document Type: Article

References (24)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
2. Torres D.M., Harrison S.A. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008, 134:1682-1698.
3. Park S.H., Jeon W.K., Kim S.H., et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006, 21:138-143.
4. Kim H.J., Kim H.J., Lee K.E., et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004, 164:2169-2175.
5. Kim S., Shim K., Lee H., et al. The association of nonalcoholic fatty liver disease with metabolic syndrome. J Korean Acad Fam Med 2007, 28:667-674.
6. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
7. Arslan U., Turkoglu S., Balcioglu S., et al. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis 2007, 18:433-436.
8. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
9. Saadeh S., Younossi Z.M., Remer E.M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123:745-750.
10. Steyerberg E.W., Harrell F.E., Borsboom G.J., et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001, 54:774-781.
11. Hamaguchi M., Kojima T., Itoh Y., et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007, 102:2708-2715.
12. Duman D.G., Celikel C., Tuney D., et al. Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment?. Dig Dis Sci 2006, 51:346-351.
13. Lee S.W., Park S.H., Kim K.W., et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 2007, 244:479-485.
14. Fishbein M.H., Gardner K.G., Potter C.J., et al. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 1997, 15:287-293.
15. Bedogni G., Bellentani S., Miglioli L., et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006, 6:33-39.
16. Mofrad P., Contos M.J., Haque M., et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology (Baltimore, MD) 2003, 37:1286-1292.
17. Graif M., Yanuka M., Baraz M., et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 2000, 35:319-324.
18. Joseph A.E., Saverymuttu S.H., Al-Sam S., et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991, 43:26-31.
19. Mathiesen U.L., Franzen L.E., Aselius H., et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002, 34:516-522.
20. Jee S.H., Sull J.W., Park J., et al. Body-mass index and mortality in Korean men and women. N Engl J Med 2006, 355:779-787.
21. Wang Y., Beydoun M.A. The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007, 29:6-28.
22. Min H.K. The characteristics of Korean diabetes. Korean J Diabet Assoc 1992, 16:163-173.
23. Min H.K., Yoo H.J., Lee H.K., et al. Changing patterns of the prevalence of diabetes mellitus in Korea. Korean J Diabet Assoc 1981, 6:71.
24. Harmon R.C., Caldwell S.H. Propensity for non-alcoholic fatty liver disease: more evidence for ethnic susceptibility. Liver Int 2009, 29:4-5.